دورية أكاديمية
Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain
| العنوان: | Cost-effectiveness of atezolizumab versus pembrolizumab as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in Spain |
|---|---|
| المؤلفون: | Isla, Dolores, Lopez-Brea, Marta, Espinosa, María, Arrabal, Natalia, Pérez-Parente, Diego, Carcedo, DavidAff5, IDs1296202300417z_cor6, Bernabé-Caro, ReyesAff6, Aff7 |
| المصدر: | Cost Effectiveness and Resource Allocation. 21(1) |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 14787547 |
|---|---|
| DOI: | 10.1186/s12962-023-00417-z |